Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Follow-up data support effect of green tea catechins in preventing prostate cancer

April 4, 2008

Supratek's SP-1049C granted orphan drug designation for gastric cancer

April 3, 2008

Cougar reaches agreement with FDA under SPA for phase III clinical trial of CB-7630

April 3, 2008

DSMB supports continuation of Genta's phase III AGENDA trial of Genasense in melanoma

April 2, 2008

Acusphere licenses hydrophobic drug delivery system and AI-850 to Cephalon

April 2, 2008

NeoPharm enrolls first patients in phase II cancer trial of liposomal paclitaxel

April 1, 2008

UCB reports phase II results for CDP-791 in non-small cell lung cancer

April 1, 2008

Protectan CBLB-502 shows mitigation of hematopoietic damage post-radiation

April 1, 2008

Seattle Genetics initiates second phase I clinical trial of SGN-35 in Hodgkin's lymphoma

April 1, 2008

Positive phase III data reported for new GnRH blocker degarelix

April 1, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...